Versant Capital Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
Versant Capital Management's EDIT Position: Q3 2026 in Review
Versant Capital Management held its Editas Medicine (EDIT) position steady in Q3 2026 at 100 shares worth $257. The position accounts for ﹤0.01% of the portfolio, ranked #2784.
Versant Capital Management first reported a position in EDIT in Q3 2024 and has held it in 9 quarters since. The position peaked at $347 in Q3 2025. 221 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.
- Versant Capital Management held 100 shares of Editas Medicine worth $257 as of Q3 2026.
- Versant Capital Management left its Editas Medicine share count unchanged in Q3 2026.
- Editas Medicine made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2784 holding.
- Versant Capital Management first reported a position in Editas Medicine in Q3 2024 and has held it in 9 quarters since.
- Versant Capital Management's Editas Medicine position peaked at $347 in Q3 2025.
- 221 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.